ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 556 filers reported holding ASTRAZENECA PLC in Q1 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $249,000 | -17.5% | 5,590 | -23.7% | 0.00% | -33.3% |
| Q2 2019 | $302,000 | +18.0% | 7,324 | +15.6% | 0.00% | 0.0% |
| Q1 2019 | $256,000 | +15.8% | 6,338 | +9.1% | 0.00% | +50.0% |
| Q4 2018 | $221,000 | -30.5% | 5,810 | -27.7% | 0.00% | -33.3% |
| Q3 2018 | $318,000 | +10.8% | 8,036 | -1.6% | 0.00% | 0.0% |
| Q2 2018 | $287,000 | +7.1% | 8,163 | +6.4% | 0.00% | 0.0% |
| Q1 2018 | $268,000 | +4.3% | 7,669 | +3.4% | 0.00% | +50.0% |
| Q4 2017 | $257,000 | +3.6% | 7,420 | +1.4% | 0.00% | 0.0% |
| Q3 2017 | $248,000 | -19.2% | 7,315 | -25.8% | 0.00% | -33.3% |
| Q1 2017 | $307,000 | +20.9% | 9,853 | +6.0% | 0.00% | +50.0% |
| Q4 2016 | $254,000 | -3.4% | 9,292 | +6.8% | 0.00% | 0.0% |
| Q2 2016 | $263,000 | -37.5% | 8,699 | -41.8% | 0.00% | -50.0% |
| Q1 2016 | $421,000 | – | 14,934 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |